Clinical trials recruiting in Seogu, South Korea
3
Recruiting trials
7
Conditions
Phase breakdown
Phase 1 1Phase 3 2
Conditions recruiting in Seogu, South Korea
| Condition | Trials |
|---|---|
| Breast cancer | 1 |
| HR+/HER2- Breast Cancer | 1 |
| Hepatitis B | 1 |
| Hepatitis B Virus Infection | 1 |
| Obesity | 1 |
| Overweight | 1 |
| Type 2 diabetes | 1 |
Recruiting trials in Seogu, South Korea
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Common questions
How many clinical trials are recruiting in Seogu, South Korea?
3 recruiting trials have at least one study site in Seogu, South Korea.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.